» Articles » PMID: 32697719

Risk of Depressive Symptoms Before and After the First Hospitalisation for Cancer: Evidence from a 16-year Cohort Study in the Czech Republic

Overview
Journal J Affect Disord
Date 2020 Jul 23
PMID 32697719
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether depression risk starts increasing before cancer diagnosis, and whether cancer is an independent risk factor for depression, remain unclear. We aimed to quantify the risk of depressive symptoms before and after the first hospitalisation for cancer (as a proxy for cancer diagnosis) amongst patients with cancer.

Methods: We linked cohort data with national hospitalisation records in the Czech Republic. We followed 1056 incident cancer cases for up to 15 years before and 15 years after the first hospitalisation for cancer. Depressive symptoms were measured using the Centre for Epidemiological Studies-Depression (CES-D) scale. We used multilevel ordered logistic regression to assess the relationship between follow-up years (pre- and post-hospitalisation) and depressive symptoms amongst incident cancer cases. Propensity Score Matching was employed to match each case with a cancer-free control, to test the independent effect of cancer on depressive symptoms over time.

Results: Per one year of follow-up (whether pre- or post- hospitalisation) was associated with 1.07 (1.05-1.10) times more likely to have high severity of depressive symptoms amongst patients with cancer. The probability of having high severity of depressive symptoms increased from 25% at five years before hospitalisation to 33% at 7.5 years after hospitalisation. In parallel analyses amongst matched cancer-free controls, the risk of depressive symptoms had no significant changes during follow-up.

Limitations: Stratified analyses based on cancer types and stages of malignancy were infeasible.

Conclusions: The excess risk of depressive symptoms was apparent five years prior to the first hospitalisation for cancer. Using cancer-free matched controls, we confirmed that cancer was an independent predictor of depressive symptoms.

Citing Articles

Research progress on the psychological burden and intervention measures in cancer patients.

Wang H, Lin H, Liu B Front Psychiatry. 2024; 15:1408762.

PMID: 38938456 PMC: 11208330. DOI: 10.3389/fpsyt.2024.1408762.


Factors associated with depressive symptoms among cancer patients: a nationwide cross-sectional study.

Chen X, Ye C, Liu L, Li X BMC Public Health. 2024; 24(1):1443.

PMID: 38811910 PMC: 11137935. DOI: 10.1186/s12889-024-18898-9.


Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study.

Vilalta-Lacarra A, Vilalta-Franch J, Serrano-Sarbosa D, Marti-Lluch R, Marrugat J, Garre-Olmo J Front Psychol. 2023; 14:1192462.

PMID: 37711322 PMC: 10497951. DOI: 10.3389/fpsyg.2023.1192462.


Factors associated with and risk factors for depression in cancer patients - A systematic literature review.

Riedl D, Schussler G Transl Oncol. 2022; 16:101328.

PMID: 34990907 PMC: 8741617. DOI: 10.1016/j.tranon.2021.101328.

References
1.
Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C . Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014; 384(9948):1099-108. DOI: 10.1016/S0140-6736(14)61231-9. View

2.
Kohout F, Berkman L, Evans D . Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health. 1993; 5(2):179-93. DOI: 10.1177/089826439300500202. View

3.
Thun M, Peto R, Lopez A, Monaco J, Henley S, Heath Jr C . Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997; 337(24):1705-14. DOI: 10.1056/NEJM199712113372401. View

4.
Krishnan V, Nestler E . The molecular neurobiology of depression. Nature. 2008; 455(7215):894-902. PMC: 2721780. DOI: 10.1038/nature07455. View

5.
Herbert A, Abel G, Winters S, McPhail S, Elliss-Brookes L, Lyratzopoulos G . Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006-2015. Br J Gen Pract. 2019; 69(687):e724-e730. PMC: 6713517. DOI: 10.3399/bjgp19X705473. View